文献速递外周动脉疾病

自体静脉股腘动脉旁路术治疗腹股沟下动脉闭塞性疾病的当代结局

Contemporary Outcomes of Open Femoropopliteal Bypass by Autogenous Vein Graft in Infra-inguinal Arterial Occlusive Disease.
PubMed 文献 · Ann Vasc Surg · 2022-04-23

单中心回顾性分析2012年1月至2017年12月129例因外周动脉疾病行自体静脉股腘动脉旁路术的患者,2年一期通畅率59.2%、无截肢生存率82.1%、CLTI患者保肢率87.2%、总生存率87.8%。作者认为当代通畅率低于既往报道,但通畅率与保肢率仍满意,建议有静脉时应始终使用静脉。

要点

  • 129例自体静脉股腘旁路术,中位随访19个月(IQR 11-26)。
  • 2年一期通畅率59.2%,无截肢生存率82.1%,总生存率87.8%。
  • CLTI患者2年保肢率87.2%,作者建议有静脉时应始终使用静脉。

核心结论

  • 在当代队列中,股腘动脉旁路术的通畅率低于既往报道,可能因血管内治疗时代手术患者病情更重、病变更广泛。
  • 作者认为通畅率与保肢率仍满意,并建议有静脉时应始终使用静脉。

研究设计与样本

  • 单中心回顾性研究,纳入2012年1月至2017年12月因外周动脉疾病行自体静脉股腘动脉开放血运重建的所有患者。
  • 共129例患者接受自体静脉移植物,中位随访19个月(IQR 11-26)。
  • 主要终点为2年一期通畅率、无截肢生存率、总生存率和保肢率,结局按血管外科学会标准定义。
  • 采用单变量描述性统计,Kaplan-Meier法估计无事件生存率。

主要发现

  • 患者以男性(59.7%)、白人(72.9%)为主,平均年龄65±11岁。
  • 手术指征为致残性跛行36.4%(n=47)和慢性肢体威胁性缺血(CLTI)63.6%(n=82)。
  • 多数患者为TASC C或D级病变(n=81,62.8%),17例(16.3%)为再次旁路术。
  • 6个月、1年、2年一期通畅率分别为81.3%、68.6%、59.2%;无截肢生存率分别为93.4%、88%、82.1%。
  • CLTI患者6个月、1年、2年保肢率分别为93.4%、90.4%、87.2%;总生存率分别为97.5%、92.1%、87.8%。

临床怎么用

  • 作者认为,在有静脉可用时应始终使用静脉作为股腘动脉旁路的 conduit。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although the majority of patients presenting with symptomatic peripheral arterial disease (PAD) are treated with the endovascular first approach, a significant number of these patients still require open bypass because of the extent of atherosclerotic burden or failure of the endovascular therapy. However, data available on the outcomes of femoropoliteal bypass in the contemporary era of PAD management is scarce. In this study, we evaluate realworld mid-term outcomes of femoropopliteal bypass for PAD. METHODS: We identified all patients who underwent open femoropopliteal revascularization with autogenous vein conduits for PAD at one institution between January 2012 and December 2017. Main endpoints included primary patency, amputation-free survival, overall survival, and limb salvage at 2 years. Outcomes were defined as per the Society for Vascular Surgery standards. Descriptive statistics were performed using univariable analyses including the mean and standard deviation for continuous variables and frequency and percentage for categorical variables. Event-free survival rates were estimated using Kaplan-Meier methods. RESULTS: There were 129 patients who received autogenous vein grafts. Median follow-up was 19 months (interquartile rangeIQR 11-26). Patients were predominantly male (59.7%), white (72.9%) with a mean age of 65 ± 11 years. The indications for surgery were disabling claudication in 36.4% of patients (n = 47) and chronic limb threatening ischemia (CLTI) in 63.6% (n = 82). Most patients had Trans-Atlantic Inter-Society Consensus C or D lesions (n = 81, 62.8%). Seventeen cases (16.3%) were redoing bypasses. Arm veins and spliced vein conduits were used in 12% and 7%, respectively. In 66% of procedures, the distal anastomosis was below the knee. Primary patency estimates at 6 months, 1 year and 2 years were 81.3%, 68.6% and 59.2%, respectively. Amputation-free survival rates were 93.4%, 88% and 82.1% at 6 months, 1 year and 2 years, respectively. Limb salvage rates among patients with CLTI were 93.4%, 90.4% and 87.2% at 6 months, 1 year and 2 years, respectively. Overall survival was 97.5%, 92.1% and 87.8% at 6 months, 1 year and 2 years, respectively. CONCLUSIONS: In this contemporary cohort of patients, femoropopliteal bypass showed lower patency than previously described. The fact that bypass surgery is performed on sicker patients with more extensive disease in the endovascular era might explain this discrepancy. However, our results demonstrated satisfactory patency and limb salvage rates and suggest that vein should always be used if available.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Mathlouthi A, Zarrintan S, Khan MA, et al. Contemporary Outcomes of Open Femoropopliteal Bypass by Autogenous Vein Graft in Infra-inguinal Arterial Occlusive Disease. Ann Vasc Surg. 2022. PMID: 35470046. doi:10.1016/j.avsg.2022.04.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。